Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Shares, without par value
-
Shares outstanding
-
193M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
34.9M
-
Shares change
-
+34.6M
-
Total reported value, excl. options
-
$212M
-
Value change
-
+$211M
-
Put/Call ratio
-
0.67
-
Number of buys
-
51
-
Price
-
$6.09
Significant Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2015
55 filings reported holding ABUS - Arbutus Biopharma Corp - Common Shares, without par value as of Q3 2015.
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.9M shares
of 193M outstanding shares and own 18.02% of the company stock.
Largest 10 shareholders include QVT Financial LP (16M shares), PRIMECAP MANAGEMENT CO/CA/ (2.84M shares), Falcon Edge Capital LP (2.62M shares), HealthCor Management, L.P. (2.15M shares), FRANKLIN RESOURCES INC (2.06M shares), D. E. Shaw & Co., Inc. (1.86M shares), MILLENNIUM MANAGEMENT LLC (1.36M shares), AXA (798K shares), CITADEL ADVISORS LLC (755K shares), and SABBY MANAGEMENT, LLC (725K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.